Print Edition - 2019-02-15 | MONEY
PM Oli inaugurates livestock vaccine plant in Kavre
Feb 15, 2019-
Hester Biosciences Nepal, the joint-venture company of Golchha Organisation and Hester Biosciences India, has launched a new plant in Kavre. It is expected to produce 46 livestock vaccines once it comes into full operation.The company said that they have obtained licence to produce 17 livestock vaccines and are in the process to get licences for 29 more livestock vaccines. The plant was inaugurated by Prime Minister KP Sharma Oli at Nala Ugrachandi on Wednesday. The company said it has invested Rs650 million in the project.
The current production capacity of the plant is 1.20 billion doses and can be further expanded to increase output three-fold, said Rajiv Gandhi, founder of Hester. “We are aiming to make Nepal sufficient in livestock vaccines and even plan to export to Asian and African countries.” Gandhi said that his company has already secured orders of Rs150 million this year.
He said that if the Nepal government accords priority for livestock vaccines, they can even produce vaccines for avian influenza (bird flu) and others. “We hope to set up a disease diagnostic lab for disease surveillance in animals across the country.”
Shekhar Golchha, executive director of Golchha Organisation, said that the government should accord high priority for the promotion of animal health care companies in Nepal since the demand of livestock production has been increasing. “The government should also support vaccine manufacturing companies to make Nepal self-sufficient in animal vaccines and to eradicate PPR disease in sheep and goats globally.”
Addressing the inauguration programme, Prime Minister Oli said that Nepal is a country where most people’s source of income is livestock farming. “The operation of Hester Biosciences in Nala will facilitate farmers in livestock production which contributes towards economy growth, increase in household income and urbanisation.”
He said that more than 90 percent of the vaccines from Hester Biosciences are exported. “With this plant in Nepal, there will be ample number of jobs created and revenue generation as well.”
The company currently employs 50 people and is planning to hire 100 more in the next two years.
Published: 15-02-2019 12:01